W2O Becomes Real Chemistry, a Global Health Innovation Company

March 2021

Healthcare is undergoing a radical transformation that has only accelerated since the outbreak of COVID-19. To evolve along with the changing healthcare landscape, earlier this month W2O Group announced that it has transformed into a new kind of healthcare company named Real Chemistry. Discern Health, which was acquired by W2O in July 2020, is now a part of Real Chemistry, a global health innovation company. Real Chemistry is designed to address the forces driving healthcare disruption, including digitization, consumerization, and value-based care.

After 20 years, this new chapter integrates W2O’s 12 acquisitions to deliver data-driven, tech-enabled health solutions. Real Chemistry is a unified company that combines award-winning expert services in digital marketing, creative and communications with clinical trial, health economics and outcomes, and value, pricing and access advisory expertise. All of these expert services are powered by proprietary data and technology that deliver comprehensive health solutions for the challenges facing healthcare companies today.

Learn more about the change here.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

New Report: Recommendations for Patient and Family Engagement in Measure Development

Harnessing the stories, ideas, and innovations of patient and caregiver partners is the key to making measurement meaningful. With support from the Patient-Centered Outcomes Research Institute (PCORI)...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO